In the recent cancer prioritisation at Bangladesh and NCD Focus, how do you see the prospects of serving patients at Bangladesh?
This will surely open new doors for the cancer patients in Bangladesh.
The recent commitment on Universal Health Coverage will also be the key instrument to serve cancer patients.
As the government is keen to serve patients and ensure innovative medicines, we expect the regulatory authority will continue to support us so that we can also serve the patients.
What are the future plans and vision of Roche and Roche Bangladesh?